Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene

被引:97
作者
Hansen, T
Echwald, SM
Hansen, L
Moller, AM
Almind, K
Clausen, JO
Urhammer, SA
Inoue, H
Ferrer, J
Bryan, J
Aguilar-Bryan, L
Permutt, MA
Pedersen, O
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] Glostrup Univ Hosp, Hagedorn Res Inst, Copenhagen, Denmark
[3] Glostrup Univ Hosp, Ctr Prevent Med, Copenhagen, Denmark
[4] Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO USA
[5] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO USA
[6] Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA
[7] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
关键词
D O I
10.2337/diabetes.47.4.598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The high-affinity sulfonylurea receptor (SUR1) is, as a subunit of the ATP-sensitive potassium channel, an important regulator of insulin secretion in the pancreatic beta-cell. The aim of this study was to examine if genetic variability of the SUR1 gene was associated with NIDDM or altered pancreatic beta-cell function. Mutational analysis of all the 39 SUR1 exons, including intron-exon boundaries, in 63 NIDDM patients revealed two missense variants, five silent variants in the coding region, and four intron variants. The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC --> ACT, Thr759Thr and a c --> t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians. The Asp673Asn variant in exon 14 was only identified in one NIDDM patient, and the allelic frequency of the Ser1369Ala was similar among 247 control subjects (0.38 [95% CI 0.34-0.42]) and 406 NIDDM patients (0.40 [0.37-0.43]). The allelic frequency of the silent exon 18 Thr775Thr variant was 0.051 (0.035-0.067) in NIDDM patients (n = 392) and 0.027 (0.013-0.041) in control subjects (n = 246; chi(2) = 4.99, P = 0.03). The allelic frequency of the intron variant was similar among NIDDM patients (0.45 [0.42-0.48]) and control subjects (0.44 [0.40-0.48]). Of 386 NIDDM patients, 17 had the combined genotype exon 18 C/T and intron -3c/-3t (0.044 [0.024-0.064]), whereas 3 of 243 control subjects had the same combined genotype (0.012 [0-0.026]; chi(2) = 4.87, P = 0.03; odds ratio: 3.69 [1.07-12.71]). Of 380 unrelated, healthy, young Danish Caucasians, 10 (0.026 [0.010-0.042]) had the combined at-risk genotype. These subjects had, on average, a 50% reduction in serum C-peptide and a 40% reduction in serum insulin responses upon tolbutamide injection (P = 0.002 and P = 0.05, respectively) but; normal serum C-peptide and insulin responses upon glucose injection. In conclusion, a silent polymorphism in exon 18 of the SUR1 gene is associated with NIDDM in a Danish Caucasian population. In combination with an intron variant, the association is higher, and young, healthy carriers of the intragenic combination have reduced serum C-peptide and insulin responses to a tolbutamide load.
引用
收藏
页码:598 / 605
页数:8
相关论文
共 35 条
  • [1] INSULIN RESISTANCE DUE TO MUTATIONS OF THE INSULIN-RECEPTOR GENE - AN OVERVIEW
    ACCILI, D
    CAMA, A
    BARBETTI, F
    KADOWAKI, H
    KADOWAKI, T
    TAYLOR, SI
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1992, 15 (11) : 857 - 864
  • [2] CLONING OF THE BETA-CELL HIGH-AFFINITY SULFONYLUREA RECEPTOR - A REGULATOR OF INSULIN-SECRETION
    AGUILARBRYAN, L
    NICHOLS, CG
    WECHSLER, SW
    CLEMENT, JP
    BOYD, AE
    GONZALEZ, G
    HERRERASOSA, H
    NGUY, K
    BRYAN, J
    NELSON, DA
    [J]. SCIENCE, 1995, 268 (5209) : 423 - 426
  • [3] AMINO-ACID POLYMORPHISMS OF INSULIN-RECEPTOR SUBSTRATE-1 IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    ALMIND, K
    BJORBAEK, C
    VESTERGAARD, H
    HANSEN, T
    ECHWALD, S
    PEDERSEN, O
    [J]. LANCET, 1993, 342 (8875) : 828 - 832
  • [4] ANDERSEN L, 1993, CLIN CHEM, V39, P578
  • [5] PROPERTIES AND FUNCTIONS OF ATP-SENSITIVE K-CHANNELS
    ASHCROFT, SJH
    ASHCROFT, FM
    [J]. CELLULAR SIGNALLING, 1990, 2 (03) : 197 - 214
  • [6] Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians - Analysis of the impact of gender, body fat, physical fitness, and life-style factors
    Clausen, JO
    BorchJohnsen, K
    Ibsen, H
    Bergman, RN
    Hougaard, P
    Winther, K
    Pedersen, O
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (05) : 1195 - 1209
  • [7] DISEASE ASSOCIATIONS - CHANCE, ARTIFACT, OR SUSCEPTIBILITY GENES
    COX, NJ
    BELL, GI
    [J]. DIABETES, 1989, 38 (08) : 947 - 950
  • [8] PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW
    DEFRONZO, RA
    BONADONNA, RC
    FERRANNINI, E
    [J]. DIABETES CARE, 1992, 15 (03) : 318 - 368
  • [9] PRODUCTION OF ANTISERA TO SYNTHETIC BENZYLOXYCARBONYL-C-PEPTIDE OF HUMAN PROINSULIN
    FABER, OK
    MARKUSSEN, J
    NAITHANI, VK
    BINDER, C
    [J]. HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1976, 357 (06): : 751 - 757
  • [10] CHARACTERIZATION OF 7 C-PEPTIDE ANTISERA
    FABER, OK
    BINDER, C
    MARKUSSEN, J
    HEDING, LG
    NAITHANI, VK
    KUZUYA, H
    BLIX, P
    HORWITZ, DL
    RUBENSTEIN, AH
    [J]. DIABETES, 1978, 27 : 170 - 177